| |
| |
|
| Insider
Information: |
Wills Robert James |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
25,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,426 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,000 |
|
|
| Total
Value |
$3,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Director |
2024-04-08 |
10,000 |
2015-03-02 |
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2016-09-06 |
0 |
Premium* |
|
|
Milestone Pharmaceuticals Inc. |
MIST |
Director |
2022-10-19 |
15,000 |
2022-10-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2024-04-08 |
4 |
B |
$8.96 |
$27,655 |
D/D |
3,086 |
10,000 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2024-03-28 |
4 |
B |
$8.48 |
$58,602 |
D/D |
6,914 |
6,914 |
2.39 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
|
– • – |
2024-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2024-02-23 |
4 |
S |
$9.04 |
$8,859 |
D/D |
(980) |
0 |
0 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
Director |
– • – |
2022-10-19 |
4 |
B |
$4.93 |
$73,950 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2018-06-26 |
4 |
B |
$16.75 |
$83,750 |
D/D |
5,000 |
137,344 |
2.81 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2017-08-01 |
4 |
B |
$6.83 |
$34,221 |
D/D |
5,000 |
30,000 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2016-10-14 |
4 |
A |
$0.81 |
$99,999 |
D/D |
123,456 |
1,323,456 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2016-09-06 |
4 |
B |
$2.43 |
$60,858 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2016-06-16 |
4 |
B |
$0.65 |
$65,360 |
D/D |
100,000 |
1,200,000 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2015-05-14 |
4 |
B |
$0.98 |
$35,711 |
D/D |
36,440 |
100,000 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2015-05-13 |
4 |
B |
$0.88 |
$8,536 |
D/D |
9,700 |
63,560 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2015-05-11 |
4 |
B |
$0.80 |
$3,088 |
D/D |
3,860 |
53,860 |
2.73 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2015-05-08 |
4 |
B |
$0.80 |
$40,000 |
D/D |
50,000 |
50,000 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Executive Chairman |
• • – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
